Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joy S Tea

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Neural Development|February 3, 2011
The chromatin remodeling factor Bap55 functions through the TIP60 complex to regulate olfactory projection neuron dendrite targetingJoy S Tea, Liqun Luo
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 28, 2010
Histone deacetylase Rpd3 regulates olfactory projection neuron dendrite targeting via the transcription factor ProsperoJoy S Tea, Takahiro Chihara, Liqun Luo
Cold Spring Harbor Protocols|February 5, 2014
Mosaic analysis with double markers (MADM) in miceJ Sebastian Espinosa, Joy S Tea, Liqun Luo
Journal of Visualized Experiments : Jove|November 20, 2014
Dissection and mounting of Drosophila pupal eye discsJoy S Tea, Albert Cespedes, Daniel Dawson, et al.
Development (Cambridge, England)|March 17, 2022
The Blimp-1 transcription factor acts in non-neuronal cells to regulate terminal differentiation of the Drosophila eyeHongsu Wang, Carolyn A Morrison, Neha Ghosh, et al.
Molecular Cell|March 7, 2020
Dynamic Regulation of Mitochondrial Import by the Ubiquitin SystemLilian Phu, Christopher M Rose, Joy S Tea, et al.
Nature|June 5, 2014
The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagyBaris Bingol, Joy S Tea, Lilian Phu, et al.
Nature Cell Biology|January 27, 2015
USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondriaChristian N Cunningham, Joshua M Baughman, Lilian Phu, et al.
Nature Medicine|November 6, 2019
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trialThomas Powles, Mark Kockx, Alejo Rodriguez-Vida, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trialThomas Powles, Mark Kockx, Alejo Rodriguez-Vida, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Neural Development|February 3, 2011
The chromatin remodeling factor Bap55 functions through the TIP60 complex to regulate olfactory projection neuron dendrite targetingJoy S Tea, Liqun Luo
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 28, 2010
Histone deacetylase Rpd3 regulates olfactory projection neuron dendrite targeting via the transcription factor ProsperoJoy S Tea, Takahiro Chihara, Liqun Luo
Cold Spring Harbor Protocols|February 5, 2014
Mosaic analysis with double markers (MADM) in miceJ Sebastian Espinosa, Joy S Tea, Liqun Luo
Journal of Visualized Experiments : Jove|November 20, 2014
Dissection and mounting of Drosophila pupal eye discsJoy S Tea, Albert Cespedes, Daniel Dawson, et al.
Development (Cambridge, England)|March 17, 2022
The Blimp-1 transcription factor acts in non-neuronal cells to regulate terminal differentiation of the Drosophila eyeHongsu Wang, Carolyn A Morrison, Neha Ghosh, et al.
Molecular Cell|March 7, 2020
Dynamic Regulation of Mitochondrial Import by the Ubiquitin SystemLilian Phu, Christopher M Rose, Joy S Tea, et al.
Nature|June 5, 2014
The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagyBaris Bingol, Joy S Tea, Lilian Phu, et al.
Nature Cell Biology|January 27, 2015
USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondriaChristian N Cunningham, Joshua M Baughman, Lilian Phu, et al.
Nature Medicine|November 6, 2019
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trialThomas Powles, Mark Kockx, Alejo Rodriguez-Vida, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trialThomas Powles, Mark Kockx, Alejo Rodriguez-Vida, et al.
Pageof 2